日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Alpha-Ketoglutarate: A Metabolic Regulator of Cellular Homeostasis and Pathophysiology

α-酮戊二酸:细胞稳态和病理生理的代谢调节因子

Wu, Lijuan; Mai, Liyi; Wang, Hongnian; Huang, Jinxin; He, Xinrong; Zhan, Xueyun; Khalemsky, Anna; Kumar, Vijaya Arun; Paxton, James H; Tsilimingras, Dionyssios; Hachimi-Idrissi, Said; Liu, Shan W; Savioli, Gabriele; Rathlev, Niels K; Tazarourte, Karim; Slagman, Anna; Christ, Michael; Qureshi, Muhammad; Hariri, Hani; Grossman, Shamai A; Hu, Bei; Wang, Huajun; He, Binbin; Levy, Phillip D; O'Neil, Brian J; Gemme, Seth; Kurland, Lisa; Lang, Eddy; Lin, Jinle; Liang, Huiying; Li, Xin; Bellou, Abdelouahab; Grijalva-Flores, Dagoberto; Resendiz, Marino J E; Seerapu, Venkata N; Amaresan, Rajalakshmi; Gopal, Udhayakumar; Gziut-Rudkowska, Aneta I; Kern, Adam; Bojko, Krystian; Gil, Robert J; Bil, Jacek; Devulapalli, Vinay; Sathiyamurthi, Akash; Gautam, Surabhi; Bhattaram, Pallavi

Dedicated Bifurcation Stents vs. Regular Drug-Eluting Stents in Coronary Bifurcation Treatment: A Systematic Review and Meta-Analysis of 1-Year and 4-Year Outcomes, Including Left Main and Non-Left Main Subgroup Comparisons

冠状动脉分叉病变治疗中专用分叉支架与常规药物洗脱支架的比较:1年和4年疗效的系统评价和荟萃分析,包括左主干和非左主干亚组比较

Bil, Jacek; Kern, Adam; Gziut-Rudkowska, Aneta I; Zalewski, Jarosław; Bojko, Krystian; Gil, Robert J

The Randomized, Multicenter, Open-Label, Controlled POLBOS 3 Trial Comparing Regular Drug-Eluting Stents and the Sirolimus-Eluting BiOSS LIM C Dedicated Coronary Bifurcation Stent: Four-Year Results

一项随机、多中心、开放标签、对照的POLBOS 3试验比较了常规药物洗脱支架和西罗莫司洗脱的BiOSS LIM C专用冠状动脉分叉支架:四年结果

Gil, Robert J; Kern, Adam; Bojko, Krystian; Gziut-Rudkowska, Aneta; Vassilev, Dobrin; Bil, Jacek